[HTML] plos.org

[HTML][HTML] Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PLoS …, 2013 - journals.plos.org
Background Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
被引用次数：92 相关文章

[引用][C] Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PLoS …, 2013 - ui.adsabs.harvard.edu
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria
Vaccine Candidate BK-SE36 - NASA/ADS Now on home page ads icon ads Enable full ADS …

Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

NM Palacpac, E Ntege, A Yeka, B Balikagala, N Suzuki… - Plos one, 2013 - europepmc.org
Background Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …

Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PloS …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …

Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PLoS …, 2013 - search.ebscohost.com
Background: Up to now a malaria vaccine remains elusive. The< i> Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
[PDF] semanticscholar.org

[PDF][PDF] BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - 2013 - pdfs.semanticscholar.org
Background: Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
[PDF] researchgate.net

[PDF][PDF] BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - 2013 - researchgate.net
Background: Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
[PDF] academia.edu

[PDF][PDF] BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - 2013 - academia.edu
Background: Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
[HTML] nih.gov

[HTML][HTML] Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PLoS ONE, 2013 - ncbi.nlm.nih.gov
Background Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …

[引用][C] Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PLoS ONE, 2013 - cir.nii.ac.jp
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria
Vaccine Candidate BK-SE36 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …